TransMedics Group, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the law firm at no cost to learn more about recovering their losses
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to R...
NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Co...
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report ...
TransMedics Stock Is Worth $0 According to This Short-Seller. Here's Why I'm Not Selling.
In this video, I will talk about TransMedics (TMDX -5.16%) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.
Berman Tabacco Announces Investigation of TransMedics Group, Inc. (TMDX) Concerning Claims by Scorpion Capital
BOSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco announces that it is investigating potential securities law violations by TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:T...
Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX
PHILADELPHIA, PA / ACCESSWIRE / January 10, 2025 / Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or...
TMDX ALERT: TransMedics Group, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
Shares of TransMedics Group are down following an investigative report by Scorpion Capital. Block & Leviton is investigating TMDX for securities fraud.
1 Super Growth Stock Down 63% to Buy Hand Over Fist in 2025
Leading organ transplant technology provider TransMedics (TMDX 3.90%) increased sales by more than 100% in 10 straight quarters from early 2022 to mid-2024. However, after delivering revenue growth...
Breaking Into Healthcare: Why TransMedics Is My Bold First Move
TransMedics is transforming organ transplants with advanced technology and integrated logistics. Strong market demand and expanding adoption support long-term growth potential despite the recent to...
TransMedics Stock Plunges 57.5% in Three Months: What's Next?
TMDX is enhancing its current focus on making meaningful progress across each of its growth initiatives. However, macro challenges are likely to hurt its performance.
Is TransMedics Stock a Buy Before 2025?
In today's video, I will discuss recent updates about TransMedics (TMDX -2.36%). Watch the short video to learn more, consider subscribing, and click the special offer link below.
Down Over 60%, Is TransMedics Stock a Buy on the Dip?
TransMedics Group (TMDX 3.03%) was a top-performing stock that more than doubled in value during the months between the end of 2023 and late August.
Why Transmedics Group Stock Plummeted 21% This Week
Shares of Transmedics Group (TMDX 2.13%) sank over 20% this week, according to data from S&P Global Market Intelligence. The organ transplant disrupter announced a CFO transition and reduced the ra...
1 Top Growth Stock Down 56% to Buy After Its Recent Pullback
In this video, I will talk about recent updates regarding TransMedics (TMDX 3.34%). Watch the short video to learn more, consider subscribing, and click the special offer link below.
Down 52%, Is TransMedics Stock a Buy on the Dip?
Sales growth is tapering off for this provider of delivery services for transplant organs.
Related Companies